Search research articles
Contact Us
Filters
Showing results (211-220 of 241) with videos related to
Page
of 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2007
Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis
Mayra Arias, Fernanda C Q Mello, Ada Pavón, et al.
Journal of Clinical Microbiology
|
August 19, 2007
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin
Fernanda C Q Mello, Mayra S Arias, Senia Rosales, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
|
October 31, 2025
Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil
Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza, et al.
The New England Journal of Medicine
|
December 14, 2011
Three months of rifapentine and isoniazid for latent tuberculosis infection
Timothy R Sterling, M Elsa Villarino, Andrey S Borisov, et al.
Annals of the American Thoracic Society
|
February 3, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials
Ruth N Moro, Nigel A Scott, Andrew Vernon, et al.
Trials
|
July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)
Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis
Susan E Dorman, John L Johnson, Stefan Goldberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2026
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial
Violet Chihota, Zainab Waggie, Vicky Cardenas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2025
Effectiveness of a Home-based Approach to Child Contact Investigation and TPT Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial
Nicole Salazar-Austin, Silvia Cohn, Bareng A S Nonyane, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 241) with videos related to
Sort By:
Page
of 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2007
Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis
Mayra Arias, Fernanda C Q Mello, Ada Pavón, et al.
Journal of Clinical Microbiology
|
August 19, 2007
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin
Fernanda C Q Mello, Mayra S Arias, Senia Rosales, et al.
Open Forum Infectious Diseases
|
January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial
Moises A Huaman, Manuel G Feria, Michelle A Kendall, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia
|
October 31, 2025
Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil
Isadora Salles, Jamile Garcia de Oliveira, Alexandra Brito de Souza, et al.
The New England Journal of Medicine
|
December 14, 2011
Three months of rifapentine and isoniazid for latent tuberculosis infection
Timothy R Sterling, M Elsa Villarino, Andrey S Borisov, et al.
Annals of the American Thoracic Society
|
February 3, 2018
Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials
Ruth N Moro, Nigel A Scott, Andrew Vernon, et al.
Trials
|
July 25, 2023
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)
Akash Malhotra, Bareng Aletta Sanny Nonyane, Evan Shirey, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis
Susan E Dorman, John L Johnson, Stefan Goldberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2026
Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial
Violet Chihota, Zainab Waggie, Vicky Cardenas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2025
Effectiveness of a Home-based Approach to Child Contact Investigation and TPT Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial
Nicole Salazar-Austin, Silvia Cohn, Bareng A S Nonyane, et al.
Page
of 25